Present status of clinical researches on the screening for prostate cancer biomarkers.
- Author:
Yue HE
1
;
Guo-dong QIN
;
Ming-zhao XIAO
Author Information
1. Department of Urology, The First Hospital Affiliated to Chongqing Medical University, Chongqing 400016, China. yueyue0826@163.com
- Publication Type:Journal Article
- MeSH:
Biomarkers, Tumor;
Early Detection of Cancer;
Humans;
Male;
Prostatic Neoplasms;
diagnosis
- From:
National Journal of Andrology
2011;17(11):1029-1032
- CountryChina
- Language:Chinese
-
Abstract:
Researches on the biomarkers of tumors are very important for their early diagnosis and treatment. Although PSA has been used for over 20 years for screening prostate cancer and evaluating its treatment, the results are not entirely satisfactory. With the deepening of the researches on prostate cancer, a variety of prostate cancer biomarkers have been found. This article presents an overview on the recent advances in the screening for prostate cancer biomarkers.
